Doctor recommending a Medicine to a patient

DEA Expands Telemedicine Access for Buprenorphine Prescriptions: What It Means for...

By: Christopher Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Provider Defense and Compliance Firm The Drug Enforcement Administration (DEA), in collaboration with the Department of Health and Human...

Read More ›
Couple sitting on sofa with laptop

DEA’s Long-Awaited Proposed Rule: A Step Forward or a Step Back...

By: Christopher Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Provider Defense and Compliance Firm The Drug Enforcement Administration (DEA) has announced the creation of a special registration process...

Read More ›
Hands of a person using tablet

Phishing Attack Leads to $3 Million HIPAA Settlement: Lessons for Healthcare...

By: Christopher Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Provider Defense and Compliance Firm The U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) has announced a...

Read More ›
Medical Debt message on paper

The Biden Administration Bans Medical Debt from Credit Reports

By: Christopher Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Provider Defense and Compliance Firm In a groundbreaking move, the Biden administration has taken a bold step to protect American...

Read More ›
Suitcase with pile of cash.

UnitedHealth Units Ordered to Pay $165 Million to Massachusetts Consumers for...

By: Christopher Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Provider Defense and Compliance Firm In a landmark decision, three UnitedHealth-owned insurance companies have been ordered to pay...

Read More ›
Group of people having a meeting

Sham Speaker Programs and Fraudulent Kickbacks: Novartis Faces FCA Allegations

By: Christopher Parrella, Esq., CPC, CHC, CPCO Parrella Health Law, Boston, Ma. A Health Care Provider Defense and Compliance Firm The Second Circuit recently reignited allegations against Novartis Pharmaceuticals...

Read More ›